PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

NCT02557321 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: PV-10
DRUG: Pembrolizumab

Sponsor

Provectus Biopharmaceuticals, Inc.